Datopotamab deruxtecan (ADC)

• Description :

  Datopotamab deruxtecan is an ADC consisting of a TROP2-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of breast cancer.

• Product Name Alternative :

  DS-1062a

• Reactivity :

  Human

• Applications :

  Research Grade Biosimilar

• Stability :

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.

• Endotoxin :

  Please contact with the lab for this information.

• Purity :

  >90% as determined by SEC.

• Form :

  Liquid

• Notes :

  For research use only. Not suitable for clinical or therapeutic use.